MUNICH, GERMANY, March 4, 2011 -- The new year has started well for Nanion; in the first weeks of 2011 more than five Patchliners were sold and shipped to academic institutions, intended for advanced ion channel research and screening projects, and are soon to be followed by the first SyncroPatch 96 shipment and installation.
NORTH BRUNSWICK, NJ, USA, February 1, 2011 -- Nanion welcomes Dr. Joerg Oestreich to the team. With Dr. Oestreich’s strong background in electrophysiology screening assays, Nanion continues to offer premium support for the US-market.
MUNICH, GERMANY, December 16, 2010 -- Researches from the LMU and Nanion Developed a Planar Patch Clamp Approach to Characterize Ionic Currents from Intact Lysosomes
Since its launch in the early 1980s, the patch clamp method has been extensively used to study ion channels in the plasma membrane, but its application to the study of intracellular ion channels has been limited. Unlike the plasma membrane, intracellular membranes are usually not stable enough to withstand mechanical manipulation by glass electrodes during seal formation and rupturing of the membrane. To circumvent these problems, we developed a method involving the immobilization of isolated organelles on a solid matrix planar glass chip. This glass chip contains a microstructured hole that supports the formation of gigaseals and subsequent electrophysiological recordings despite the high fragility of intracellular membranes.
MUNICH, GERMANY, April 19, 2010 -- 'Increased freedom to operate for everyone in automated patch clamping'
Nanion Technologies GmbH (Nanion), a supplier of automated, parallel patch-clamp systems based in Munich, Germany, today announced that a Board of Appeal of the European Patent Office (EPO) has overturned an earlier decision of the Opposition Division to uphold patent EP 1,040,349 owned by Molecular Devices, Inc. (MDC).
Read the full press release here.